A specific miRNA signature in the peripheral blood of glioblastoma patients. - Wikidata - awgldk - TriplyDB

A specific miRNA signature in the peripheral blood of glioblastoma patients.

A specific miRNA signature in the peripheral blood of glioblastoma patients.

http://www.wikidata.org/entity/Q45256953

about

The Role of Mir-148a in Cancer MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics The potential of tumor-derived exosomes for noninvasive cancer monitoring Exploring miRNA-Associated Signatures with Diagnostic Relevance in Glioblastoma Multiforme and Breast Cancer Patients Circulating glioma biomarkers MicroRNAs as biomarkers for CNS disease Developing epigenetic diagnostics and therapeutics for brain disorders Emerging methods for disease monitoring in malignant gliomas Combining Radiation Therapy with Immune Checkpoint Blockade for Central Nervous System Malignancies Blood-based biomarkers for malignant gliomas MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations.Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC.The human miRNA repertoire of different blood compounds.miRTrail--a comprehensive webserver for analyzing gene and miRNA patterns to enhance the understanding of regulatory mechanisms in diseases.Next-generation sequencing identifies novel microRNAs in peripheral blood of lung cancer patients.Genome-wide profiling identified a set of miRNAs that are differentially expressed in glioblastoma stem cells and normal neural stem cells.MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape.MicroRNA expression profiles of whole blood in lung adenocarcinoma miRNAs can be generally associated with human pathologies as exemplified for miR-144.Circulating miRNA biomarkers for Alzheimer's disease Glioblastoma extracellular vesicles: reservoirs of potential biomarkers.miR-218 inhibits the migration and invasion of glioma U87 cells through the Slit2-Robo1 pathway.An integrated mRNA and microRNA expression signature for glioblastoma multiforme prognosis.Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma Analysis of Glioblastoma Patients' Plasma Revealed the Presence of MicroRNAs with a Prognostic Impact on Survival and Those of Viral Origin.Belonging to a network--microRNAs, extracellular vesicles, and the glioblastoma microenvironment.Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas miR-320b suppresses cell proliferation by targeting c-Myc in human colorectal cancer cells Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures Increased oncogenic microRNA-18a expression in the peripheral blood of patients with prostate cancer: A potential novel non-invasive biomarker.Distinct AGO1 and AGO2 associated miRNA profiles in human cells and blood plasma.Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma.MiR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ECOP-mediated suppression of NF-κB activity.Inhibition of miR-21 in glioma cells using catalytic nucleic acids Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer.MiR-106a is an independent prognostic marker in patients with glioblastoma.Epigenetics and ncRNAs in brain function and disease: mechanisms and prospects for therapy.Whole miRNome-wide differential co-expression of microRNAs.A Signature of Circulating microRNAs Predicts the Susceptibility of Acute Mountain Sickness.

P2860

Q26743549-B53CDE97-EC36-46D6-B385-3F9274DDC2B5 Q26747273-796810B6-CE02-4CA1-8E8F-C19D3253CAF7 Q26796396-675C3E52-131B-4FB0-925A-C2057F3622DA Q26796590-A94D17DD-6D4D-4E12-88A8-6238DF207CAF Q26830329-AD2BACD6-6FD7-4D79-A8A5-094593E0C970 Q27013998-2A2E1B81-4419-4394-8752-88CC519A7D2B Q27022987-D658E612-BE94-4740-8C9D-61FFABB23049 Q27023823-A0C77982-84E0-48E9-AF4C-8DE4194658FA Q28072007-5A293FD7-13F8-495C-B735-E0A27ADE37E0 Q30625411-5D4DB0D6-B2FA-409B-BFBE-18F5481B044D Q33648875-EEB127F5-608B-46F1-9228-C0F36FF670B6 Q33827178-6F2F3A64-A5E0-4207-A941-4F2BA2B9F805 Q33828257-6844B246-5E39-48DD-A266-C252A428334B Q34166883-B34D53CE-BC68-4844-B96D-9194659FD086 Q34227491-A3B5642F-97F8-4F6F-90C9-B11A9B529D73 Q34257360-E6C21270-81DE-4F10-824B-FA6B1F69E32C Q34365811-4FFFA609-B544-443D-BC40-9EAE48AF1360 Q34430694-5DBBFEC0-C165-4987-8DA1-DF4FBE599FA3 Q34720619-8F8FD11A-B5D3-457B-A1F8-4453DBB50932 Q34904013-0DD1B681-4DA2-4FEF-A7E6-21DA0A86C74A Q35122209-3973456A-9DC6-4443-A576-4B8453FF2103 Q35167790-F4108BDD-9EFF-4E1D-92C8-93A35FC4453E Q35175490-A4DACB69-52F3-4D73-B157-E9E838AF219B Q35275041-C2198C67-3528-4FA1-B0B2-E8B6097102D0 Q35581594-6EEFA9B5-9D7F-4028-A1F3-A74A227125E2 Q35788575-C77FD9A3-BDC2-45A0-A16A-82713979B3B2 Q35788900-30889872-AD85-4065-B735-79DE1D9FF45D Q36091092-EAAA0DFE-E225-44FB-83C0-AE1BE1812675 Q36199659-35E42B69-CBF1-4D60-AD67-7143622C1EFB Q36268697-7AD652A7-05F2-450A-97B1-85E9216CD5D7 Q36524546-C3723962-2E82-4EFD-9C90-93CF00605CC7 Q36552828-E7F878EF-4D80-482D-9519-AC4387B8DF57 Q36560956-3B0FBF59-0E67-487C-8228-38FED2C79593 Q36713464-2C1D5081-2A4B-495A-AFCA-7A4C7F5D73AE Q36799623-E62B3D52-143E-4F13-B856-E9110F885CB4 Q36840404-3AC68BC9-4B8E-4A08-AC52-E5ACA3C748E7 Q36865988-9DFECFF0-A1FA-46D8-B48B-C7703C0282FC Q37249131-7E5A07E5-FC85-4DB2-AA41-B04608A68A3B Q37318575-B47549E6-1376-4AAB-9270-DE5EEC10E867 Q37629842-A9CCE794-0F1A-45AF-9CCF-E40C13CB2C0E

P2860

A specific miRNA signature in the peripheral blood of glioblastoma patients.

http://www.wikidata.org/entity/Q45256953

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

A specific miRNA signature in the peripheral blood of glioblastoma patients.

@en

A specific miRNA signature in the peripheral blood of glioblastoma patients.

@nl

type

label

A specific miRNA signature in the peripheral blood of glioblastoma patients.

@en

A specific miRNA signature in the peripheral blood of glioblastoma patients.

@nl

prefLabel

A specific miRNA signature in the peripheral blood of glioblastoma patients.

@en

A specific miRNA signature in the peripheral blood of glioblastoma patients.

@nl

P1433

Q45256953-428604FE-C6BA-4FD2-9426-7445F70A5E8B

P1476

Q45256953-47024A4B-A3D5-4A44-B4DA-6478B6085884

P2093

Q45256953-0F86F56C-CA20-48A1-977D-6B7B0726E60D

Q45256953-3A3288E9-6878-4095-84EC-FEFDC5DFB4A5

Q45256953-C2968B0E-ABEF-4F87-88C2-87A2BC491B91

Q45256953-F794C89B-0C13-4E9A-B33B-98D626FC98C7

Q45256953-F833423C-28D1-417C-B64F-08703D421DBD

Q45256953-FE933A51-A557-47EC-8E54-8695B21A533E

P2860

Q45256953-0536FF33-A9D6-4793-8578-A00947A75313

Q45256953-095C2AD9-2BB3-4CEF-9567-C53856E11A5E

Q45256953-15636E7C-76EF-4BF5-A247-CB570601FA16

Q45256953-18BFADB9-3514-448E-9AC5-7367981635DA

Q45256953-1DBCFD6D-6F5D-4C34-9687-5E4A3BF1EFD6

Q45256953-1F8730CD-2E38-4698-8023-770259937231

Q45256953-21F9D9F6-A6EF-4C04-9B3F-3BFC625CAB5E

Q45256953-26A40483-78B5-4947-94F1-F06486195676

Q45256953-34D8C454-34E8-4563-81A9-DE54F7D616D1

Q45256953-3A7B5CF5-81C6-49CC-B5ED-91F19A77D4DA

P304

Q45256953-CA71C9F1-F9E7-46D9-815A-168D2AEBDAD0

P31

Q45256953-F0ECF1B0-4F20-4B5C-AFF8-5B811B642DCD

P356

Q45256953-158A4192-197F-4668-8059-F87A51A8019C

P407

Q45256953-70E9A203-097A-45E0-9059-6C0E1DB76372

P433

Q45256953-63B3872F-FFAB-4CC0-8F2F-3D6D10D36AD1

P478

Q45256953-07DBB0BB-DEF5-4C3B-A0A4-6C5BD99CCE7E

P50

Q45256953-C92C0300-C4EE-400C-954D-F2986CE2850C

Q45256953-EFBCD59A-514E-4D82-81B2-59E77729FDE1

P577

Q45256953-DE1F2587-C232-4320-8AC5-672CD375F268

P5875

Q45256953-89B80ABF-FB16-4033-905C-2F6198577801

P698

Q45256953-BD7C0137-0C06-4A78-B4D6-2B24BB57AF8A

P921

Q45256953-64C09330-D08D-4834-852B-D7181431BFA5

P356

J.1471-4159.2011.07307.X

P1433

Journal of Neurochemistry

P1476

A specific miRNA signature in the peripheral blood of glioblastoma patients.

@en

P2093

Andreas Keller

http://www.w3.org/2001/XMLSchema#string

Caroline Happold

http://www.w3.org/2001/XMLSchema#string

Günter Eisele

http://www.w3.org/2001/XMLSchema#string

P Anoop Chandran

http://www.w3.org/2001/XMLSchema#string

Patrick Roth

http://www.w3.org/2001/XMLSchema#string

Silvia Hofer

http://www.w3.org/2001/XMLSchema#string

P2860

Serum microRNAs are promising novel biomarkers

Rfam: annotating non-coding RNAs in complete genomes

miRBase: tools for microRNA genomics

miR2Disease: a manually curated database for microRNA deregulation in human disease

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

MicroRNA signatures in human cancers

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

Extensive modulation of a set of microRNAs in primary glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Controlling the false discovery rate in behavior genetics research

P304

449-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1471-4159.2011.07307.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Jörg Wischhusen

P577

2011-06-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51116405

http://www.w3.org/2001/XMLSchema#string

P698

21561454

http://www.w3.org/2001/XMLSchema#string

P921